Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system

Journal of Human Hypertension

Volumn 19, Issue 8, 2005, Pages 659-661

  Libhaber, E N ^a   Norton, G R ^a   Libhaber, C D ^a   Candy, G P ^a   Woodiwiss, A J ^a   Sliwa, K ^a   Essop, M R ^a   Sareli, P ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; RAMIPRIL;

ADULT; AFRICA; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; POPULATION RESEARCH; PROSPECTIVE STUDY; REMISSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIOMEGALY; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION;

EID: 23644454439     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001879     Document Type: Article

References (12)

1. Okin PM et al for the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) Study Investigators. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol. Circulation 2003; 108: 684-690.
2. Malmqvist K et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 2001; 19: 1167-1176.
3. Devereux RB et al. Regression of hypertensive left ventricular hypertrophy to losartan compared with atenolol:the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004; 11: 1456-1462.
4. Nystrom F, Malmqvist K, Ohman KP, Kahan T. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study. J Hypertens 2002; 20: 1527-1533.
5. Sareli P et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects. Results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001; 161: 965-971.
6. Middlemost SJ, Tager R, Davis J, Sareli P. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide vs enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol 1994; 73: 1092-1097.
7. Koren MJ et al. Comparison of left ventricular mass and geometry in black and white patients with essential hypertension. Am J Hypertens 1993; 6: 815-823.
8. Lee DK et al. Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence. J Am Med Assoc 1992; 267: 3294-3299.
9. Mogensen CE et al for the CALM study. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and noninsulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 2000; 321: 1440-1444.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation 1978; 58: 1072-1083.
11. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens 1991; 9: 573-574.
12. Skudicky D et al. Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients. Circulation 2002; 105: 830-837.